Evidence map›Paper›PMID 30568990›Full record

ReviewOpen forum infectious diseases2018

Emerging

S Seyedmousavi, M S Lionakis, M Parta, S W Peterson, K J Kwon-Chung

Open access · goldAbstract readReview
In one paragraph

Review in Open forum infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. BeyondAntimicrobial agents and chemotherapy · 2026
    Article
  4. Article
  5. Successful Management of Spondylodiscitis Caused byJournal of fungi (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Evaluation of the Activity of Triazoles Against Non-Open forum infectious diseases · 2024
    Article
  8. Dermatitis, cellulitis, and osteomyelitis caused byJournal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc · 2024
    Article
  9. Drug-ResistantPathogens (Basel, Switzerland) · 2023
    Review
  10. Review
  11. Diagnosis and Treatment of Invasive Aspergillosis Caused by Non-Journal of fungi (Basel, Switzerland) · 2023
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Studies in mycology · 2021
    Review
  17. Article
  18. Genetic susceptibility to fungal infection in children.Current opinion in pediatrics · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

S SeyedmousaviMolecular Microbiology Section, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0002-6194-7447
M S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
M PartaClinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research, sponsored by the National Cancer Institute, Frederick, Maryland.
S W PetersonNational Center for Agricultural Utilization Research, US Department of Agriculture, Peoria, Illinois.
K J Kwon-ChungMolecular Microbiology Section, National Institutes of Health, Bethesda, Maryland.
National Institutes of Health · USFrederick National Laboratory for Cancer Research · USNational Center for Agricultural Utilization Research · US

Funding

Basic Studies On Aspergillus SpeciesZIAAI000657 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KWON-CHUNG, KYUNG · 2009 to 2020
$4.3M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

Invasive aspergillosis (IA) is the most serious mold infection encountered in patients with iatrogenic immunosuppression. IA is also a major cause of mortality and morbidity in individuals with primary immunodeficiency (PID). Although

Indexed as

emerging non-fumigatus Aspergillus speciesinvasive aspergillosisprimary immunodeficiencies

Identifiers

PMID30568990
PMCPMC6157306
OpenAlexW2893470964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.